Michael Barbella, Managing Editor06.29.23
Endonovo Therapeutics Inc. has launched SofPulse with Academy Medical Inc., a service-disabled veteran-owned small business (SDVOSB) government reseller.
Academy Medical is reselling SofPulse medical devices to the Veterans Health Administration (VHA) healthcare facilities, thereby ensuring its availability to the country’s military, veterans, and their families. This sales launch meeting marks the beginning of a partnership between Endonovo and Academy Medical.
"The launch of SofPulse in partnership with Academy Medical is an important element in our go-to market strategy providing an important opportunity to greatly expand its distribution throughout veterans and military healthcare facilities. Together we plan to bring better medical solutions to our veterans and their families and provide improved access SofPulse," Endonovo Medical Division President Ira Weisberg said. "We expect to sell $10 million in the next twelve into the federal supply system.”
SofPulse Included in VHA Procurement System
With its launch into the federal marketplace, Endonovo and Academy Medical can potentially significantly improve SofPulse's access to military personnel and veterans. The addition of SofPulse into the VHA procurement system allows Endonovo to sell into America's largest healthcare integrated delivery network (IDN). The procurement system is designed to streamline logistics and supply management for medical and surgical items, providing veterans and military healthcare facilities with easier access to the products they need.
Academy Medical is a provider of medical and surgical items to the federal marketplace with more than 45,000 products from 30-plus supplier partners. “The partnership between Academy Medical and Endonovo provides veterans an opportunity to benefit from the device’s unique PEMF technology,” Academy Medical CEO Tory Crawford, a U.S. Army veteran.
The two companies' partnership aims to provide better access to medical and surgical supplies, along with telehealth solutions, with the goal of making a tangible impact on the lives of those who have served their country. The VHA, which serves 9 million enrolled veterans annually through its 1,298 healthcare facilities, including 171 medical centers and 1,113 outpatient sites, will benefit from the inclusion of SofPulse medical devices in the VHA procurement system.
Endonovo's SofPulse PEMF devices provide a clinically proven and U.S. Food and Drug Administration (FDA)-cleared alternative to opioid pain management, specifically for reducing postoperative pain and edema. With the launch of sales initiatives surrounding the partnership, Academy Medical aims to expand the distribution of SofPulse devices, benefiting military personnel and veterans with improved recovery times and reduced opioid use. Endonovo's commercialization of the SofPulse line is led by Weisberg.
Endonovo's mission to revolutionize medical solutions for patients with a range of conditions includes advancing its patented technology for central nervous system (CNS) and traumatic brain injury (TBI). The VA partnership with Academy Medical is expected to create significant R&D and growth prospects for SofPulse. In addition, recent FDA clearance inquiries could lead to further partnerships. Endonovo Therapeutics is currently structured into two divisions: Legacy – a commercial-stage developer primarily of noninvasive wearable Electroceuticals therapeutic devices for pain relief, general wellness, and wound curatives with many of its products marketed under the SofPulse brand name; and its Build Up Strategy – acquiring complementary specialty service providers in the construction industry.
Academy Medical is a premier SDVOSB and distributor of medical-surgical equipment and supplies to the U.S. government. As a government procurement partner with industry expertise and access to advanced technology, Academy Medical’s mission is to leverage its preferred status as an SDVOSB to create a streamlined, more cost-effective process for its government customers and supplier partners. The company is headquartered in West Palm Beach, Fla.
Academy Medical is reselling SofPulse medical devices to the Veterans Health Administration (VHA) healthcare facilities, thereby ensuring its availability to the country’s military, veterans, and their families. This sales launch meeting marks the beginning of a partnership between Endonovo and Academy Medical.
"The launch of SofPulse in partnership with Academy Medical is an important element in our go-to market strategy providing an important opportunity to greatly expand its distribution throughout veterans and military healthcare facilities. Together we plan to bring better medical solutions to our veterans and their families and provide improved access SofPulse," Endonovo Medical Division President Ira Weisberg said. "We expect to sell $10 million in the next twelve into the federal supply system.”
SofPulse Included in VHA Procurement System
With its launch into the federal marketplace, Endonovo and Academy Medical can potentially significantly improve SofPulse's access to military personnel and veterans. The addition of SofPulse into the VHA procurement system allows Endonovo to sell into America's largest healthcare integrated delivery network (IDN). The procurement system is designed to streamline logistics and supply management for medical and surgical items, providing veterans and military healthcare facilities with easier access to the products they need.
Academy Medical is a provider of medical and surgical items to the federal marketplace with more than 45,000 products from 30-plus supplier partners. “The partnership between Academy Medical and Endonovo provides veterans an opportunity to benefit from the device’s unique PEMF technology,” Academy Medical CEO Tory Crawford, a U.S. Army veteran.
The two companies' partnership aims to provide better access to medical and surgical supplies, along with telehealth solutions, with the goal of making a tangible impact on the lives of those who have served their country. The VHA, which serves 9 million enrolled veterans annually through its 1,298 healthcare facilities, including 171 medical centers and 1,113 outpatient sites, will benefit from the inclusion of SofPulse medical devices in the VHA procurement system.
Endonovo's SofPulse PEMF devices provide a clinically proven and U.S. Food and Drug Administration (FDA)-cleared alternative to opioid pain management, specifically for reducing postoperative pain and edema. With the launch of sales initiatives surrounding the partnership, Academy Medical aims to expand the distribution of SofPulse devices, benefiting military personnel and veterans with improved recovery times and reduced opioid use. Endonovo's commercialization of the SofPulse line is led by Weisberg.
Endonovo's mission to revolutionize medical solutions for patients with a range of conditions includes advancing its patented technology for central nervous system (CNS) and traumatic brain injury (TBI). The VA partnership with Academy Medical is expected to create significant R&D and growth prospects for SofPulse. In addition, recent FDA clearance inquiries could lead to further partnerships. Endonovo Therapeutics is currently structured into two divisions: Legacy – a commercial-stage developer primarily of noninvasive wearable Electroceuticals therapeutic devices for pain relief, general wellness, and wound curatives with many of its products marketed under the SofPulse brand name; and its Build Up Strategy – acquiring complementary specialty service providers in the construction industry.
Academy Medical is a premier SDVOSB and distributor of medical-surgical equipment and supplies to the U.S. government. As a government procurement partner with industry expertise and access to advanced technology, Academy Medical’s mission is to leverage its preferred status as an SDVOSB to create a streamlined, more cost-effective process for its government customers and supplier partners. The company is headquartered in West Palm Beach, Fla.